Citation Numbers: 23 A.D.3d 546, 807 N.Y.S.2d 603
Filed Date: 11/21/2005
Status: Precedential
Modified Date: 11/1/2024
Ordered that the orders are affirmed insofar as appealed from, with one bill of costs.
The plaintiff alleged that his deceased wife (hereinafter the decedent) contracted lung cancer from smoking cigarettes for more than 20 years that were manufactured, promoted, and/or sold by the appellants. The appellants are five cigarette
The Supreme Court properly denied those branches of the appellants’ respective motions which were for summary judgment dismissing the causes of action to recover damages for fraudulent concealment occurring after 1969; specifically, after the effective date of the federal Cigarette Labeling and Advertising Act, as amended by the Public Health Cigarette Smoking Act of 1969 (15 USC § 1331 et seq.) (hereinafter the Act). The appellants’ claim that these causes of action are preempted by the Act is virtually identical to the claim raised in and rejected by this Court in Miele v American Tobacco Co. (2 AD3d 799, 801-803 [2003]). As the plaintiff in that case asserted, the plaintiff herein asserts that the appellants “suppressed, ignored, and disregarded test results not favorable to the tobacco industry” and “willfully and intentionally failed to disclose the material facts regarding the dangerous and addictive nature, properties, and propensities of the cigarette by controlling and suppressing material facts.” We held that inasmuch as “the predicate duty underlying the plaintiff’s fraudulent concealment claims is a state-law duty not to deceive . . . the Supreme Court improperly held that [the] post-1969 fraudulent concealment causes of action were preempted by the Act” (Miele v American Tobacco Co., supra at 803). Similarly, in this case, the Supreme Court properly denied those branches of the appellants’ respective motions which were for summary judgment dismissing the causes of action alleging fraudulent concealment after 1969 on preemption grounds. Further, we are unpersuaded by the appellants’ suggestion that our decision in Miele v American Tobacco Co. (supra), should be revisited and overturned.
There is no merit to the claim that the manufacturer appellants should have been awarded summary judgment dismissing the causes of action to recover damages for post-1969 strict product liability and negligent design defects on the ground that cigarettes were in a condition reasonably contemplated by the ultimate consumer (see Miele v American Tobacco Co., supra at 804). “ ‘[Cjonsumer expectations do not constitute an independent standard for judging the defectiveness of product designs . . . The mere fact that a risk presented by a product design is open and obvious, or generally known, and that the
While the manufacturer appellants suggest that New York applies a consumer expectations test to design defect causes of action, the Court of Appeals made clear in Denny v Ford Motor Co. (87 NY2d 248 [1995]) that the determination of whether a design defect is actionable requires a balancing of the risks and utilities of the product, with the consumer’s degree of awareness of the product’s potential danger being but one factor to consider in that analysis (see Scarangella v Thomas Built Buses, 93 NY2d 655 [1999]; Micallef v Miehle Co., Div. of Miehle-Goss Dexter, 39 NY2d 376, 387 [1976]; Miele v American Tobacco Co., supra at 804). The plaintiffs design defect causes of action as against the manufacturer appellants, therefore, were not, as they suggest, “subject to dismissal based solely on the conclusion that, as a matter of law, after 1969 when warnings were required to be included on cigarettes, cigarettes were in the condition contemplated by consumers at the time of purchase.”
The evidence submitted by the plaintiff in opposition to the manufacturer appellants’ respective motions for summary judgment, particularly the affidavit of William A. Farone, a scientist formerly employed by the appellant Philip Morris Incorporated, in which he stated that the manufacturer appellants opted not to develop, pursue, or exploit available technologies to reduce the toxins in cigarettes which cause disease, sufficed to raise an issue of fact as to whether the foreseeable risk of harm posed by cigarettes could have been reduced or avoided by the adoption of a reasonable alternative design by the manufacturer appellants (see Miele v American Tobacco Co., supra at 804-805). “It is ineluctable that, based upon the evidence presented by the plaintiff, a jury may determine that the tobacco companies’ objective was to entrap the cigarette smoker to preserve and enhance their economic objectives” (Miele v American Tobacco Co., supra at 805). Therefore, the Supreme Court properly denied those branches of the manufacturing appellants’ respec
The appellants’ remaining contentions are without merit. Cozier, J.P., Ritter, Rivera and Lunn, JJ., concur.